Stephenc Piscitelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephenc piscitelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephenc Piscitelli Today - Breaking & Trending Today

Dermavant Sciences: Dermavant to Present Data from ADORING 1 and 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children as Young as 2 Years Old with Atopic Dermatitis at the 2023 EADV Congress

Dermavant Sciences: Dermavant to Present Data from ADORING 1 and 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children as Young as 2 Years Old with Atopic Dermatitis at the 2023 EADV Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Robert Bissonnette , Kima Papp , Stephenc Piscitelli , Philipm Brown , Eli Lilly , Jeannetter Jakus , Neilj Korman , John Browning , Roccot Serrao , Pearl Kwong , Lawrencef Eichenfield , Eric Simpson , Annam Tallman , Davids Rubenstein , Matthewc Somerville , Laurence Watts , Jonathani Silverberg , April Armstrong , Angela Salerno Robin , Dermavant Sciences Gmb , Linkedin Dermavant Sciences , Roivant Sciences , Dermavant Sciences Inc , European Academy Of Dermatology , Iqvia National Prescription Audit , Dermavant Sciences ,

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021


Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that two abstracts from Dermavant s two pivotal Phase 3 trials for tapinarof for the treatment of psoriasis in adults, PSOARING 1 and PSOARING 2, will be presented during the upcoming American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), on April 23-25, 2021.
Tapinarof is being developed as a novel, once-daily therapeutic aryl hydrocarbon receptor modulating agent (TAMA), cosmetically elegant, steroid-free topical cream for the treatment of plaque psoriasis and atopic dermatitis.
The following posters will be viewable on the conference platform for the entirety of the conference: ....

United States , April Armstrong , Paul Yamauchi , Laurence Watts , Mark Lebwohl , Stephenc Piscitelli , Philipm Brown , Laurak Ferris , Bruce Strober , Josephf Merola , Annam Tallman , Robert Bissonnette , Angela Salerno Robin , Neal Bhatia , Kostenloser Wertpapierhandel , Howard Sofen , Lawrencej Green , Davids Rubenstein , Andrew Blauvelt , Seemalr Desai , American Academy Of Dermatology Virtual Meeting , Roivant Sciences , Program For Tapinarof , Dermavant Sciences , Linkedin Dermavant Sciences , American Academy ,